Paper26316010
Genetically diverse serotypes III and VI substitute major clonal disseminated serotypes Ib and V as prevalent serotypes of Streptococcus agalactiae from 2007 to 2012.
Wang YH and 5 others. J Microbiol Immunol Infect, 2016. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Genetically diverse serotypes III and VI substitute major clonal disseminated serotypes Ib and V as prevalent serotypes of Streptococcus agalactiae from 2007 to 2012. Papers, record 26316010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26316010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Genetically diverse serotypes III and VI substitute major clonal disseminated serotypes Ib and V as prevalent serotypes of Streptococcus agalactiae from 2007 to 2012.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Genetic Variation | Major topic |
| Streptococcal Infections | Major topic |
| Streptococcus agalactiae | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Child | |
| Child, Preschool | |
| Drug Resistance, Multiple, Bacterial | |
| Electrophoresis, Gel, Pulsed-Field | |
| Female | |
| Humans | |
| Infant | |
| Male | |
| Middle Aged | |
| Multilocus Sequence Typing | |
| Multiplex Polymerase Chain Reaction | |
| Serogroup | |
| Serotyping | |
| Taiwan | |
| Young Adult |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40831737 | Prevalence, risk factors, and serotypes of group B Streptococcus rectovaginal colonization among pregnant women: a cross-sectional study at three hospitals in Hanoi, Vietnam. | Ther Adv Infect Dis | 2025 | https://conductscience.org/library/papers/40831737 | PubMed |
| 36677330 | Molecular Epidemiology of Group B Streptococcus Colonization in Egyptian Women. | Microorganisms | 2022 | https://conductscience.org/library/papers/36677330 | PubMed |
| 36297202 | Alterations in Genes rib, scpB and Pilus Island Decrease the Prevalence of Predominant Serotype V, Not III and VI, of Streptococcus agalactiae from 2008 to 2012. | Pathogens | 2022 | https://conductscience.org/library/papers/36297202 | PubMed |
| 31537886 | Clinical and Microbiological Characteristics of Group B Streptococcus from Pregnant Women and Diseased Infants in Intrapartum Antibiotic Prophylaxis Era in Taiwan. | Sci Rep | 2019 | https://conductscience.org/library/papers/31537886 | PubMed |
| 31316488 | Genomic Insights Into the Distribution and Evolution of Group B Streptococcus. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31316488 | PubMed |
| 30833941 | Molecular Characteristics and Antimicrobial Resistance of Group B Streptococcus Strains Causing Invasive Disease in Neonates and Adults. | Front Microbiol | 2019 | https://conductscience.org/library/papers/30833941 | PubMed |
| 29160197 | Isolation and molecular characterization of group B Streptococcus from laboratory Long-Evans rats (Rattus norvegicus) with and without invasive group B streptococcal disease. | J Med Microbiol | 2018 | https://conductscience.org/library/papers/29160197 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26316010
GET https://conductscience.org/api/papers/v1/26316010/authors